ASNC/Pfizer Young Investigator in Cardiac Amyloidosis Research Fellowship Award
ASNC is pleased to announce the launch of a new opportunity for early-career members. The Pfizer Young Investigator in Cardiac Amyloidosis Research Award will provide support to eligible investigators for a mentored research project exploring the role of nuclear cardiology in the early detection of TTR cardiac amyloidosis.
- Increase opportunities for clinical research focused on cardiac amyloidosis and to improve early diagnosis, timely referral to amyloid experts, and knowledge of emerging treatment options.
- Improve outcomes of patients with ATTR-CM.
- Encourage and support careers in nuclear cardiology research while growing the science of cardiac imaging and advancing the specialty.
- Promote research in nuclear cardiology among young investigators.
- Create platform for research projects in the area of advancing early detection of TTR cardiac amyloidosis utilizing nuclear cardiology.
- Provide an "initial" grant for young investigators that will serve as a stepping stone to larger awards.
- Promote the field of nuclear cardiology by supporting new and innovative research.
$50,000 for one year
Number of Awards
March 15, 2020 – Application site opens
June 19, 2020 – Applications due, 11:59 PM EST
September 24-27, 2021 – Presentation of preliminary results at ASNC2021 in Orlando, FL
- Hold an MD, PhD or equivalent degree
- Are post-doctoral fellows or faculty in the first three years of appointment on the date of the application deadline
- Intend to pursue an academic career in nuclear cardiology
- Are ASNC members
The applicant may not have current overlapping funding from another organization to supplement their proposed work.
Applications will be reviewed against the following criteria:
- Scientific merit (significance) with focus on the potential for the project to generate data for a successful peer-reviewed grant application
- Innovation and role in early detection or monitoring of TTR cardiac amyloidosis
- Investigator qualifications with focus on the potential for the principal investigator to develop into an independent investigator
- Quality of mentor and training environment – letter of reference from mentor
- Research benefit for the field of nuclear cardiology
A numerical scoring system from 1.0 to 5.0 -- 1.0 is highest; 2.5 is mid-range; 5.0 is lowest.
Applications must be submitted online at portal.asnc.org.
Sponsored by: Pfizer Inc.